[go: up one dir, main page]

AR105177A2 - Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-(4.3.0)nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolincarboxílico - Google Patents

Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-(4.3.0)nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolincarboxílico

Info

Publication number
AR105177A2
AR105177A2 ARP160101954A ARP160101954A AR105177A2 AR 105177 A2 AR105177 A2 AR 105177A2 AR P160101954 A ARP160101954 A AR P160101954A AR P160101954 A ARP160101954 A AR P160101954A AR 105177 A2 AR105177 A2 AR 105177A2
Authority
AR
Argentina
Prior art keywords
chinolincarboxyl
cyclopropil
diazabiciclo
ciano
nonan
Prior art date
Application number
ARP160101954A
Other languages
English (en)
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of AR105177A2 publication Critical patent/AR105177A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Trihidrato de pradofloxacina, como a composiciones antibacterianas que lo contienen.
ARP160101954A 2004-04-01 2016-06-28 Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-(4.3.0)nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolincarboxílico AR105177A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004015981A DE102004015981A1 (de) 2004-04-01 2004-04-01 Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure

Publications (1)

Publication Number Publication Date
AR105177A2 true AR105177A2 (es) 2017-09-13

Family

ID=34962324

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP050101004A AR048099A1 (es) 2004-04-01 2005-03-15 FORMA CRISTALINA DE ÁCIDO 8-CIANO-1CICLOPROPIL-7-(1S,6S-2,8-DIAZABICICLO)(4.3.0)NONAN--IL)-6FLUOR-1,4-DIHIDRO-4-OXO-3-QUINOLINCARBOXíLICO
ARP160101954A AR105177A2 (es) 2004-04-01 2016-06-28 Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-(4.3.0)nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolincarboxílico

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP050101004A AR048099A1 (es) 2004-04-01 2005-03-15 FORMA CRISTALINA DE ÁCIDO 8-CIANO-1CICLOPROPIL-7-(1S,6S-2,8-DIAZABICICLO)(4.3.0)NONAN--IL)-6FLUOR-1,4-DIHIDRO-4-OXO-3-QUINOLINCARBOXíLICO

Country Status (31)

Country Link
US (1) US7977484B2 (es)
EP (1) EP1737859B1 (es)
JP (1) JP5190259B2 (es)
KR (1) KR101217678B1 (es)
CN (1) CN100591681C (es)
AR (2) AR048099A1 (es)
AT (1) ATE450536T1 (es)
AU (1) AU2005231918B2 (es)
BR (1) BRPI0509529B8 (es)
CA (1) CA2561635C (es)
CY (2) CY1109762T1 (es)
DE (3) DE102004015981A1 (es)
DK (1) DK1737859T3 (es)
ES (1) ES2335899T3 (es)
GT (1) GT200500043A (es)
HR (1) HRP20100097T1 (es)
IL (1) IL178353A (es)
MY (1) MY140998A (es)
NO (1) NO337279B1 (es)
NZ (1) NZ550226A (es)
PE (1) PE20060170A1 (es)
PL (1) PL1737859T3 (es)
PT (1) PT1737859E (es)
RU (1) RU2383543C2 (es)
SI (1) SI1737859T1 (es)
SV (1) SV2006002070A (es)
TW (1) TWI350755B (es)
UA (1) UA84329C2 (es)
UY (1) UY28828A1 (es)
WO (1) WO2005097789A1 (es)
ZA (1) ZA200608072B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
ES2886088T3 (es) 2017-02-13 2021-12-16 Bayer Animal Health Gmbh Composición líquida que contiene pradofloxacina
CN115710267A (zh) * 2022-11-30 2023-02-24 天津大学 一种普拉沙星水合物晶体及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19546249A1 (de) * 1995-12-12 1997-06-19 Bayer Ag Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen
WO1997031001A1 (de) 1996-02-23 1997-08-28 Bayer Aktiengesellschaft Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854357A1 (de) 1998-11-25 2000-05-31 Bayer Ag Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE19908448A1 (de) * 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
PL1737859T3 (pl) 2010-04-30
NZ550226A (en) 2009-11-27
IL178353A (en) 2011-08-31
JP5190259B2 (ja) 2013-04-24
KR20070014157A (ko) 2007-01-31
ZA200608072B (en) 2008-01-08
DE122011100055I1 (de) 2012-03-15
NO337279B1 (no) 2016-02-29
ATE450536T1 (de) 2009-12-15
DE502005008620D1 (de) 2010-01-14
BRPI0509529A (pt) 2007-09-18
TWI350755B (en) 2011-10-21
GT200500043A (es) 2006-02-17
BRPI0509529B1 (pt) 2019-05-21
SI1737859T1 (sl) 2010-03-31
DE102004015981A1 (de) 2005-10-20
RU2006138362A (ru) 2008-05-10
CA2561635A1 (en) 2005-10-20
HRP20100097T1 (hr) 2010-04-30
EP1737859B1 (de) 2009-12-02
ES2335899T3 (es) 2010-04-06
US7977484B2 (en) 2011-07-12
AU2005231918B2 (en) 2011-05-12
KR101217678B1 (ko) 2013-01-02
BRPI0509529B8 (pt) 2021-05-25
PT1737859E (pt) 2010-02-03
EP1737859A1 (de) 2007-01-03
CA2561635C (en) 2012-10-16
TW200602053A (en) 2006-01-16
MY140998A (en) 2010-02-12
CN100591681C (zh) 2010-02-24
UY28828A1 (es) 2005-11-30
CN1938304A (zh) 2007-03-28
WO2005097789A1 (de) 2005-10-20
UA84329C2 (en) 2008-10-10
US20080125458A1 (en) 2008-05-29
CY2011018I1 (el) 2016-12-14
IL178353A0 (en) 2007-02-11
DK1737859T3 (da) 2010-04-06
AR048099A1 (es) 2006-03-29
CY1109762T1 (el) 2014-09-10
PE20060170A1 (es) 2006-04-13
RU2383543C2 (ru) 2010-03-10
NO20064988L (no) 2006-10-31
HK1104537A1 (en) 2008-01-18
SV2006002070A (es) 2006-03-15
AU2005231918A1 (en) 2005-10-20
JP2007530614A (ja) 2007-11-01

Similar Documents

Publication Publication Date Title
UA107791C2 (en) Pesticidal compositions
HN2003000094A (es) Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
DK2137196T3 (da) Tricykliske nitrogenholdige forbindelser som antibakterielle midler
EA201300756A1 (ru) Композиции для осветления цвета кожи
CR9260A (es) COMPUESTOS DE BIS ARILO Y HETEROARILO SUSTITUIDOS COMO ANTAGONISTAS SELECTIVOS DE 5HT2a
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
MX2009011456A (es) Aumento de la productividad de las plantas por combinacion de agentes quimicos con modificaciones transgenicas.
EA201200143A1 (ru) Антибактериальная композиция для ротовой полости
TW200730490A (en) Photoactive compounds
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
NI200500139S (es) Mordedor para perro caso 29/223,860
MX2010002243A (es) Derivados fungicidas de 2-alquiltio-2-quinoliniloxi-acetamida.
MA29873B1 (fr) Composes
MA32647B1 (fr) Composés pyrrole
DE602005007488D1 (de) Zusammensetzung mit interkalierten funktionell aktiven organischen verbindungen
AR105177A2 (es) Forma cristalina de ácido 8-ciano-1-ciclopropil-7-(1s,6s-2,8-diazabiciclo-(4.3.0)nonan-8-il)-6-flúor-1,4-dihidro-4-oxo-3-quinolincarboxílico
UY31688A1 (es) Plaguicidas
BRPI0923048A2 (pt) "composto de aminopirazol".
PA8855001A1 (es) Monocarbamas
CR20110381A (es) Antagonistas de 4-azetidinil-1-heteroaril-ciclohexanol de ccr2
WO2011037773A3 (en) Synergistic antimicrobial composition
MX2009007336A (es) Indazoles substituidos con 5-furopiridinona.
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
HN2009000856A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
BRPI0914940A8 (pt) Composições nutritivas contendo punicalaginas

Legal Events

Date Code Title Description
FC Refusal